Senscent cell-derived inhibitors of DNA synthesis
US6372249B1 · kind B1 · utility
37Cited by
9References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 24, 1994 |
| Grant date | Apr 16, 2002 |
| Priority date | — |
| Expiry date | Oct 24, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/322
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of liposomal formulations, particularly formulations of positively charged and neutral lipids facilitates cellular uptake of SDI molecules. The transcription and/or expression of SDI-1-encoding nucleic acid molecules is facilitated by constructs that contain intervening untranslated regions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.